EnBiotix, Inc. — Form D
EnBiotix, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. The offering totals $5.0M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-04-05
- Form: D
- Accession: 0001789774-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.5M
- Remaining: $1.5M
- Investors: 11
- Date of first sale: 2019-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-440344
Issuer
- Name: EnBiotix, Inc.
- CIK: 0001789774
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 197 W SPRINGFIELD STREET, BOSTON, MA, 02118
- Phone: 508-400-1856
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Dennis D Auisello | Director | Boston, MA |
| Roberto D Guttmann | Director | Boston, MA |
| Daniel D Hartman | Director | Boston, MA |
| Jeffrey D Wager | Director | Boston, MA |
| Jeffrey D Wager | Executive Officer | Boston, MA |
| Dennis D Ausiello | Director | Boston, MA |
Other filings by this issuer (1)
More